Healthcare IT News May 11, 2020
Nathan Eddy

Despite his high profile and the deep pockets of its investors, the Amazon, Berkshire Hathaway and JP Morgan Chase joint venture has so far shown limited progress on its aspirational tech-driven healthcare goals.

Atul Gawande, who in 2018 was appointed CEO of Haven, the nonprofit healthcare venture launched by the founders of Amazon, JP Morgan Chase & Co. and Berkshire Hathaway, is in “advanced discussions” to step down from the role, according to a Dow Jones report.

WHY IT MATTERS
Dr. Gawande, a surgeon and Harvard professor, was tapped to lead the then-unnamed joint venture nearly two years ago in 2018. Haven’s much-publicized debut positioned it as a disruptive force in the healthcare industry that would harness technology to lower costs...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Payer, Self-insured
What the Medicaid unwinding means for plans, providers, and more
What Impact is AI Having on the Collection and Analysis of RWE?
25 payers among Forbes' best employers for diversity
Humana Reports $741 Million Profit And Boosts Medicare Forecast
Humana withdraws 2025 earnings outlook on unsatisfactory MA rates

Share This Article